Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
TEVA
$39.53
+0.56%
TEVA
· Teva Pharmaceutical Industries Ltd
Market Cap
$45.67B
Shares
1.17B
Volume · Oct 2
4.77M
Avg daily vol (3M)
5.34M
All webcasts
Earnings call · FY2023 Q2
Teva Pharmaceutical Industries Ltd (TEVA) Q2 2023 Earnings Call
Forward guidance
1 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue
$3.88B
+2.4% YoY
Diluted EPS
-$0.78
Gross margin
46.3%
-1.1 pp YoY
Net income
-$872.00M
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Aug 2, 2023.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
Tax Rate
table
2023
|
14% – 17% | Non-GAAP |
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 2, 2023 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 2, 2023 · complete as-filed document